CLINICAL_TRIALS
trial_result
· 2018-05-16
Clinical Trial Update: Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial update for Pf-04965842 in adults with moderate-to-severe atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-05-16